Bibliographic Details
| Title: |
The use of 99mTc‐tetrofosmin in the characterisation of indeterminate renal masses: a pilot study. |
| Authors: |
Spiro, Ergi, Murtazaliev, Salikh, Amindarolzarbi, Alireza, Sheikhbahaei, Sara, Jones, Krystyna M., Javadi, Mehrbod S., Kaufmann, Basil, Allaf, Mohamad E., Pavlovich, Christian P., Singla, Nirmish, Solnes, Lilja B., Gorin, Michael A., Rowe, Steven P. |
| Source: |
BJU International; Dec2024, Vol. 134 Issue 6, p929-931, 3p |
| Subject Terms: |
CROSS-sectional imaging, KIDNEY tumors, PREGNANT women, COMPUTED tomography, SCINTILLATION cameras, NEPHRECTOMY |
| Abstract: |
The article in BJU International discusses a pilot study on the use of 99mTc-tetrofosmin in characterizing indeterminate renal masses. The study aimed to test the ability of 99mTc-tetrofosmin as an alternative means of renal mass characterization by imaging patients with oncocytic neoplasms or indeterminate renal masses. Results showed that 99mTc-tetrofosmin had potential as a risk-stratification tool, with a mean tumour uptake ratio of 0.32 in renal cell carcinomas and 0.9 in oncocytic neoplasms. The study suggests that 99mTc-tetrofosmin could be a promising alternative to 99mTc-sestamibi for identifying benign versus malignant renal lesions, but larger prospective studies are needed for further validation. [Extracted from the article] |
|
Copyright of BJU International is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
